|
受注:045-509-1970 |
技術サポート:tech@selleck.co.jp 平日9:00〜18:00 1営業日以内にご連絡を差し上げます |
|
Synonyms | PUN30119 | Storage (From the date of receipt) |
3 years -20°C powder | |||
| 化学式 | C35H35ClN6O5 |
||||||
| 分子量 | 655.14 | CAS No. | 1801530-11-9 | ||||
| Solubility (25°C)* | 体外 | DMSO | 100 mg/mL (152.63 mM) | ||||
| Ethanol | 100 mg/mL (152.63 mM) | ||||||
| Water | Insoluble | ||||||
| 体内 (毎回新しく調製した物を用意してください) |
|
||||||
|
* <1 mg/ml means slightly soluble or insoluble. * Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
|||||||
| 製品説明 | IKE(Imidazole ketone erastin) is a potent, selective, and metabolically stable system xc– inhibitor and inducer of ferroptosis. |
|---|---|
| in vitro | Imidazole ketone erastin (IKE) is an erastin analog with nanomolar potency, high metabolic stability, and intermediate water solubility. Its treatment potently reduces DLBCL cell number[1]. |
| 細胞アッセイ | 細胞株 | DLBCL cell line |
|---|---|---|
| 濃度 | 0-100 μM | |
| 反応時間 | 24 h | |
| 実験の流れ | DLBCL cells are plated at 10,000 cells per well in white 384-well plates (32 μL per well) in technical duplicates and incubated overnight. The cells are then treated with 8 μL medium containing a two-fold dilution series of vehicle (DMSO), IKE (starting from 100 μM) with or without Fer-1 (starting from 200 μM). After 24 h incubation, 40 μL of 50% CellTiter-Glo / 50% cell culture medium is added to each well and incubated at room temperature with shaking for 15 min. Luminescence is measured. All cell viability data are normalized to the DMSO vehicle condition. Experiments are performed three independent times with different passages for each cell line. From these data, dose-response curves and IC50 values are computed. |
|
| 動物実験 | 動物モデル | Non-obese diabetic/ severe combined immunodeficiency (NOD/SCID) mice |
| 投薬量 | 50 mg/kg | |
| 投与方法 | IP, IV and oral administration |
|
| SLC7A11 is an unconventional H+ transporter in lysosomes [ Cell, 2025, S0092-8674(25)00406-4] | PubMed: 40280132 |
| Endoplasmic reticulum-mitochondria contacts are prime hotspots of phospholipid peroxidation driving ferroptosis [ Nat Cell Biol, 2025, 27(6):902-917] | PubMed: 40514428 |
| BDH2-driven lysosome-to-mitochondria iron transfer shapes ferroptosis vulnerability of the melanoma cell states [ Nat Metab, 2025, 7(9):1851-1870] | PubMed: 40957995 |
| Targeting pancreatic cancer glutamine dependency confers vulnerability to GPX4-dependent ferroptosis [ Cell Rep Med, 2025, 6(2):101928] | PubMed: 39879992 |
| Vorapaxar enhanced mitochondria-associated ferroptosis primes cancer immunotherapy via targeting FOXO1/HMOX1 axis [ Cell Rep Med, 2025, 6(10):102371] | PubMed: 41005298 |
| Neutralization of acyl coenzyme A binding protein for the experimental prevention and treatment of hepatocellular carcinoma [ Cell Rep Med, 2025, 6(7):102232] | PubMed: 40628264 |
| SLC25A1 and ACLY maintain cytosolic acetyl-CoA and regulate ferroptosis susceptibility via FSP1 acetylation [ EMBO J, 2025, 10.1038/s44318-025-00369-5] | PubMed: 39881208 |
| Periplocin potentiates ferroptotic cell death in non-small cell lung cancer by inducing the degradation of Nrf2 [ Cancer Cell Int, 2025, 25(1):294] | PubMed: 40760694 |
| Mitochondrial phosphoenolpyruvate carboxykinase 2 counteracts ferroptosis via catalytic activity independent of mitochondrial stress [ Biochem Biophys Res Commun, 2025, 778:152383] | PubMed: 40712389 |
| Targeting lipid scrambling potentiates ferroptosis and triggers tumor immune rejection [ Sci Adv, 2025, 11(33):eadx6587] | PubMed: 40815641 |
長期の保管のために-20°Cの下で製品を保ってください。
人間や獣医の診断であるか治療的な使用のためにでない。
各々の製品のための特定の保管と取扱い情報は、製品データシートの上で示されます。大部分のSelleck製品は、推薦された状況の下で安定です。製品は、推薦された保管温度と異なる温度で、時々出荷されます。長期の保管のために必要とされてそれと異なる温度で、多くの製品は、短期もので安定です。品質を維持するが、夜通しの積荷のために最も経済的な貯蔵状況を用いてあなたの送料を保存する状況の下に、製品が出荷されることを、我々は確実とします。製品の受領と同時に、製品データシートの上で貯蔵推薦に従ってください。